Between 50% and 80% of AFib patients have sleep apnea,1 and the need for prompt diagnosis and treatment is clear:
AFib recurrence rate after cardioversion is 42% higher in patients with unmanaged obstructive sleep apnea (OSA) vs controls2*
In older males, nocturnal AFib is
more likely in those with central sleep apnea3

For sleep apnea management, WatchPAT® TurnKey does it all:

Enroll your AFib patients at risk for sleep apnea into the program. Then:

PRESCRIBE a WatchPAT® home sleep apnea test for qualified patients

THAT’S IT! The WatchPAT® TurnKey program will take it from there


*required field

Fast, easy, and seamless—you prescribe the test, we can do the rest:

Continuous patient compliance monitoring and support to ensure best-in-class outcomes
  • Designed to enhance the patient’s experience and promote treatment acceptance
  • Digital compliance dashboard available online so you can check on your patients’ status anytime you want
Helps make life easier for you, your staff and your patients

Avoids the headache of preauthorization, billing and reimbursement, with:

Request more information

*required field


References: 1. Ayache MB, Mehra R, Mayuga KA. Should I evaluate my patient with atrial brillation for sleep apnea? Clevel Clin J Med. 2019:86:709-712. DOI: 2. Shukla A, Aizer A, Holmes D, et al. Effect of Obstructive Sleep Apnea Treatment on Atrial Fibrillation Recurrence: A Meta-Analysis. JACC: Clinical Electrophysiology March 2015;1(1-2):41-51. 3. Mehra R, Stone KL, Varosy PD, et al. Nocturnal arrhythmias across a spectrum of obstructive and central sleep-disordered breathing in older men: Outcomes ofSleep Disorders in Older Men (MrOS Sleep) Study. Arch Intern Med. 2009;169(12):1147-1155. doi:10.1001/archinternmed.2009.138.

Your information will be handled in accordance with our privacy policy.

When using the marks in our publications and this website, we used the appropriate ™, ℠, or ®. The ® symbol is used to indicate registrations in the U.S. and the territories listed in and this should not mean that such trademarks are necessarily registered in other countries. For example, WatchPAT®  is a trademark of Itamar Medical Ltd., registered in the U.S. and the applicable territories listed in only.

WatchPAT® and PAT® are trademarks of Itamar Medical, Ltd. Copyright © 2021 by Itamar Medical, Ltd. All rights reserved.